Position in HLN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$14,065,329
+$752,691 QoQ
Shares Held
1,507,538
+13.4% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#42
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Derivatives in HLN
reported options exposure · as of Dec 31, 2022CallValue
$60,000
CallShares
7,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $573,447,136 across 59 Drug Manufacturers - Specialty & Generic names. HLN ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
262,200 | $142,067,824 | |
| 2 | ZTS |
Zoetis Inc.
|
1,265,210 | $90,917,989 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,527,031 | $85,615,809 | |
| 4 | VTRS |
Viatris Inc
|
4,360,444 | $69,243,850 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
179,076 | $30,181,467 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
643,006 | $26,382,535 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
189,692 | $21,044,429 | |
| 8 | HLN |
Haleon plc
This page
|
1,507,538 | $14,065,329 |
All Filings in HLN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,065,329 | 1,507,538 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $13,312,638 | 1,329,934 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $9,858,390 | 975,113 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,848,454 | 986,450 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $9,562,715 | 922,152 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $8,941,473 | 868,948 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $10,031,795 | 1,051,551 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $10,958,645 | 1,035,789 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,615,095 | 1,042,990 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $8,440,272 | 994,143 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $7,930,935 | 963,662 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $8,261,675 | 991,798 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $7,538,964 | 899,638 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $6,278,184 | 771,276 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $5,749,912 | 718,739 | Shares | Defined | 2023-02-09 | |
| 2022-12-31 | $60,000 | 7,500 | Call | Defined | 2023-02-09 | |
| 2022-09-30 | $45,675 | 7,500 | Call | Defined | 2022-11-10 | |
| 2022-09-30 | $4,253,125 | 698,379 | Shares | Defined | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||